STOCK TITAN

INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

INOVIO (NASDAQ: INO), a biotechnology company focused on DNA medicines for HPV-associated diseases, cancer, and infectious diseases, announced it will release its third quarter 2024 financial results after market close on November 14, 2024. The company will host a conference call and webcast at 4:30 p.m. ET on the same day, featuring a Q&A session with analysts. The webcast will be accessible at the company's investor relations website and will remain available for replay for 90 days.

INOVIO (NASDAQ: INO), un'azienda biotecnologica focalizzata su medicinali a base di DNA per malattie associate all'HPV, cancro e malattie infettive, ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 dopo la chiusura del mercato il 14 novembre 2024. L'azienda ospiterà una teleconferenza e un webcast alle 16:30 ET dello stesso giorno, con una sessione di domande e risposte con gli analisti. Il webcast sarà accessibile sul sito web delle relazioni con gli investitori dell'azienda e rimarrà disponibile per la riproduzione per 90 giorni.

INOVIO (NASDAQ: INO), una empresa biotecnológica centrada en medicamentos basados en ADN para enfermedades asociadas al VPH, cáncer y enfermedades infecciosas, anunció que publicará sus resultados financieros del tercer trimestre de 2024 después del cierre del mercado el 14 de noviembre de 2024. La empresa organizará una llamada de conferencia y un webcast a las 4:30 p.m. ET el mismo día, incluyendo una sesión de preguntas y respuestas con analistas. El webcast será accesible en el sitio web de relaciones con inversores de la empresa y estará disponible para reproducirse durante 90 días.

INOVIO (NASDAQ: INO)는 HPV 관련 질병, 암, 감염병을 위한 DNA 의약품에 집중하는 생명공학 회사로, 2024년 11월 14일 시장 종료 후 2024년 3분기 재무 결과를 발표할 예정이라고 발표했습니다. 회사는 같은 날 오후 4시 30분 ET에 분석가와의 질문 및 응답 세션을 포함한 전화 회의 및 웹캐스트를 개최합니다. 웹캐스트는 회사의 투자자 관계 웹사이트에서 접근 가능하며 90일 동안 다시 재생할 수 있습니다.

INOVIO (NASDAQ: INO), une entreprise biotechnologique spécialisée dans les médicaments à base d'ADN pour les maladies associées au VPH, le cancer et les maladies infectieuses, a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 après la fermeture des marchés le 14 novembre 2024. L'entreprise organisera une conférence téléphonique et un webinaire le même jour à 16h30 ET, incluant une session de questions-réponses avec des analystes. Le webinaire sera accessible sur le site web des relations avec les investisseurs de l'entreprise et sera disponible en rediffusion pendant 90 jours.

INOVIO (NASDAQ: INO), ein Biotechnologieunternehmen, das sich auf DNA-Medikamente gegen HPV-assoziierte Krankheiten, Krebs und Infektionskrankheiten spezialisiert hat, gab bekannt, dass es seine Finanzergebnisse für das dritte Quartal 2024 nach Börsenschluss am 14. November 2024 veröffentlichen wird. Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz und einen Webcast veranstalten, der eine Fragen- und Antworten-Sitzung mit Analysten umfasst. Der Webcast wird auf der Investor-Relations-Website des Unternehmens verfügbar sein und 90 Tage lang zur Wiederholung bereitstehen.

Positive
  • None.
Negative
  • None.

PLYMOUTH MEETING, Pa., Nov. 6, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases, today announced that third quarter 2024 financial results will be released after the market close on November 14, 2024. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss financial results and provide a general business update.

The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts. The webcast will be archived and available for replay for 90 days following the event.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

Contacts
Media: Jennie Willson (267) 429-8567 jennie.willson@inovio.com
Investors: Thomas Hong (267) 440-4298 thomas.hong@inovio.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-report-third-quarter-2024-financial-results-on-november-14-2024-302297260.html

SOURCE INOVIO Pharmaceuticals, Inc.

FAQ

When will INOVIO (INO) release Q3 2024 earnings?

INOVIO will release its third quarter 2024 financial results after market close on November 14, 2024.

What time is INOVIO's (INO) Q3 2024 earnings call?

INOVIO's Q3 2024 earnings conference call and webcast will take place at 4:30 p.m. ET on November 14, 2024.

How long will INOVIO's (INO) Q3 2024 earnings webcast be available for replay?

The webcast will be archived and available for replay for 90 days following the event.

Inovio Pharmaceuticals, Inc.

NASDAQ:INO

INO Rankings

INO Latest News

INO Stock Data

109.36M
25.88M
0.85%
33.51%
13.5%
Biotechnology
Surgical & Medical Instruments & Apparatus
Link
United States of America
SAN DIEGO